Skip to main content

Together we are beating cancer

Donate now

Cancer Research UK-funded research

Showing 12 out of 974 results
A green beam of light from a radiotherapy machine.

Modern radiotherapy is used to treat more than 140,000 people with cancer in the UK every year. We've brought it a long way since 1896. Here's the full story. Modern radiotherapy is used to treat more than 140,000 people with cancer in the UK every year. We've brought it a long way since 1896. Here's the full story.

by Tim Gunn | In depth | 17 February 2025

17 February 2025

Lab-grown bowel cancer cells seen through a microscope. They are colour-enhanced and appear blue.

A new testing technique with genome sequencing is 90% accurate at predicting which high-risk people with IBD will develop bowel cancer, according to a study by our scientists.  A new testing technique with genome sequencing is 90% accurate at predicting which high-risk people with IBD will develop bowel cancer, according to a study by our scientists. 

by Tim Gunn | News | 30 January 2025

30 January 2025

A group of three Cancer Research UK scientists Group of researchers looking at a data file in a lab

A first-of-its-kind drug that protects the hearing of babies, children and young people undergoing cancer treatment has been approved for NHS use in England, based on the results of one of our trials.   A first-of-its-kind drug that protects the hearing of babies, children and young people undergoing cancer treatment has been approved for NHS use in England, based on the results of one of our trials.  

by Tim Gunn | News | 28 January 2025

28 January 2025

Salmonella bacteria (rod-shaped organisms coloured blue) in a bowel cancer tumour (coloured beige). The bacteria looks like it is rushing into a hole in the tumour tissue.

Our researchers are modifying Salmonella bacteria into a treatment that can work with the immune system to attack bowel cancer from two sides at once. Our researchers are modifying Salmonella bacteria into a treatment that can work with the immune system to attack bowel cancer from two sides at once.

by Tim Gunn, Fiona MacLeod | News | 23 January 2025

23 January 2025

Two Cancer Research UK researchers working at a lab bench.

We look back on how more than 10-years of mission-based funding has transformed the UK lung cancer research ecosystem and what our new mission focused government can learn from our approach. We look back on how more than 10-years of mission-based funding has transformed the UK lung cancer research ecosystem and what our new mission focused government can learn from our approach.

by Nick Jones | Analysis | 13 January 2025

13 January 2025

A concept illustration of the tumour microenvironment

A bold change of approach by our scientists investigating what prevents immunotherapy from working in a large number of patients has led to a significant discovery that could improve outcomes across multiple cancers. A bold change of approach by our scientists investigating what prevents immunotherapy from working in a large number of patients has led to a significant discovery that could improve outcomes across multiple cancers.

by Elisa Mitchell | News | 7 January 2025

7 January 2025

A group of postgraduate researchers working in a laboratory at the University of Nottingham.
  • Science & Technology
  • Health & Medicine
  • Charity News

Getting ahead of cancer: our 2024 research highlights

The advances we made in 2024 are helping turn cancer from a disease doctors diagnose and treat to one we can seek out and stop. Here are some of our biggest stories from the past 12 months. The advances we made in 2024 are helping turn cancer from a disease doctors diagnose and treat to one we can seek out and stop. Here are some of our biggest stories from the past 12 months.

by Sadaf Shafaghmotlagh, Tim Gunn | In depth | 17 December 2024

17 December 2024

Dr Yin Cao and a colleague looking at data about cancer incidence.

Rising rates of early-onset bowel cancer are a “global phenomenon” and some of the steepest increases are happening in England, according to a major new paper we helped fund. Rising rates of early-onset bowel cancer are a “global phenomenon” and some of the steepest increases are happening in England, according to a major new paper we helped fund.

by Tim Gunn | News | 11 December 2024

11 December 2024

A cancer cell dividing.

With our funding, scientists in Cambridge have created a urine test that can detect some of the first signs of lung cancer. With our funding, scientists in Cambridge have created a urine test that can detect some of the first signs of lung cancer.

by Tim Gunn | News | 6 December 2024

6 December 2024

The capsule sponge shown in pill form and sponge form. Both are black and attached to a white thread.

Our BEST4 Screening trial will give 120,000 people with chronic heartburn a 'pill-on-a-thread' test to look for signs of Barrett's oesophagus, a rare condition that can lead to oesophageal cancer. The results will show whether the UK can use the test for a new oesophageal cancer screening programme. Our BEST4 Screening trial will give 120,000 people with chronic heartburn a 'pill-on-a-thread' test to look for signs of Barrett's oesophagus, a rare condition that can lead to oesophageal cancer. The results will show whether the UK can use the test for a new oesophageal cancer screening programme.

by Tim Gunn | Analysis | 28 November 2024

28 November 2024